Log in
Enquire now
BioAmber

BioAmber

A chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals.

OverviewStructured DataIssuesContributors

Contents

bio-amber.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Bioplastic
Bioplastic
Synthetic biology
Synthetic biology
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
‌
City Of Plymouth
Quebec
Quebec
California
California
B2X
B2B
B2B
Founder
‌
Jean-Francois Huc
‌
Nathan Johnson
AngelList URL
angel.co/bioamber
Pitchbook URL
pitchbook.com/profiles.../52155-55
Legal Name
BioAmber Inc.
Number of Employees (Ranges)
51 – 200
Email Address
info@bio-amber.com
Phone Number
+15148448000
Full Address
1250 Rene-Levesque West, Suite 4110, Montreal, Quebec H3B 4W8, CA
Investors
Mitsui Global Investment
Mitsui Global Investment
Toyota
Toyota
Mitsui
Mitsui
Agriculture and Agri-Food Canada
Agriculture and Agri-Food Canada
Lanxess
Lanxess
Export Development Canada
Export Development Canada
‌
Touradji Capital Management
Clinton Group
Clinton Group
...
Founded Date
2008
Total Funding Amount (USD)
94,000,000
Latest Funding Round Date
July 2, 2014
Competitors
BioApply
BioApply
Phytonix
Phytonix
Lyspackaging
Lyspackaging
‌
Globalyeast
‌
Cellulac PLC
Yield10 Bioscience
Yield10 Bioscience
Business Model
Commerce
Stock Symbol
BIOA
Exchange
New York Stock Exchange
New York Stock Exchange
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
4
Wellfound ID
bioamber
Country
United States
United States
Headquarters

Other attributes

Company Operating Status
Closed
Wikidata ID
Q16951804

BioAmber is a chemical company that uses biotechnology and chemical catalysis to transform renewable feedstock into chemicals that is headquartered in Montreal, Quebec and was founded in 2008. The company uses industrial biotechnology and chemical catalysis to create chemicals for several consumer products such as plastics, personal care products, resins, and food additives from renewable feedstocks.

Acquisitions
LYC Biotechnology

On October 26, 2018 BioAmber's non-operational plant in Sarnia, Ontario was sold to LYC Biotechnology for $4.34 million as a US and Canada court supervised liquidation of BioAmber. The deal required court supervision at the request of BioAmber. BioAmber made the following public statement that the company was 'facing a liquidity crisis' and it had an 'inability to raise capital on public markets as a result of its recent delisting from the New York Stock Exchange and the Toronto Stock Exchange. On June 18, 2019 LYC Biotechnology released a statement telling the public they plan on making the plant in Sarnia, Ontario operational by fall 2019.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like BioAmber

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.